Response to MEK Inhibitor Therapy in MAP2K1 ( MEK1 ) K57N Non-Small-Cell Lung Cancer and Genomic Landscape of MAP2K1 Mutations in Non-Small-Cell Lung Cancer.
Michael L ChengJessica K LeeRachit KumarHarry KleinKira RaskinaAlexa B SchrockKesi S MichaelTali MazorEthan CeramiGeoffrey R OxnardDavid R LiuHimisha BeltranLynette M ShollMizuki NishinoPasi A JannePublished in: JCO precision oncology (2022)